Galectin Therapeutics Inc.
GALT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$47,047 | -$41,066 | -$38,776 | -$30,527 |
| Dep. & Amort. | $37 | $33 | $32 | $41 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,447 | $2,261 | $2,867 | $2,076 |
| Change in WC | $2,284 | $4,678 | $4,968 | $3,751 |
| Other Non-Cash | $512 | $1,129 | -$147 | $351 |
| Operating Cash Flow | -$41,767 | -$32,965 | -$31,056 | -$24,308 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $30,000 | $30,000 | $10,000 | $30,000 |
| Stock Issued | $1,227 | $0 | $0 | $6,814 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$91 | $0 | $0 | -$171 |
| Other Fin. Act. | $91 | $10,033 | $0 | $171 |
| Financing Cash Flow | $31,227 | $40,033 | $10,000 | $36,814 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10,540 | $7,068 | -$21,056 | $12,506 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,660 | $18,592 | $39,648 | $27,142 |
| End Cash | $15,120 | $25,660 | $18,592 | $39,648 |
| Free Cash Flow | -$41,767 | -$32,965 | -$31,056 | -$24,308 |